Dogwood Therapeutics DWTX
NASDAQ DWTX
$1.88 -0.06 (-3.09%)
At close: Sep 10, 2026 · 4:00 PM EDT

Dogwood Therapeutics (DWTX) Long-Term Debt Issuances (2020 - 2025)

Dogwood Therapeutics (DWTX) posted Long-Term Debt Issuances of $3.0 million for Q1 2025, up 2300.0% on a QoQ basis from $125000.0 in Q3 2020.

Analysis

Dogwood Therapeutics (DWTX) Long-Term Debt Issuances (2020 - 2025) Analysis & Trends

Dogwood Therapeutics has reported Long-Term Debt Issuances for 2 years, with the latest figure at $3.0 million in Q1 2025.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A year-over-year to $3.0 million in Q1 2025; TTM through Dec 2025 was $3.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $3.0 million, down 80.42% from the prior year.
  • Long-Term Debt Issuances was $3.0 million for Q1 2025 at Dogwood Therapeutics, up from $125000.0 in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $3.0 million in Q1 2025, with the low at $3.0 million in Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 1.32 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Dogwood Therapeutics 65.53 Mn 65.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 3.00 Mn
Sep 30, 2020 125,000.00
Jun 30, 2020 706,633.00
Mar 31, 2020 1.16 Mn